Chromosomal Changes in relation to Clinical Outcome in Larynx and Pharynx Squamous Cell Carcinoma

Invasive head and neck squamous carcinomas are among the cytogenetically most complex tumors. Perhaps for this reason, there is little consensus on the prognostic value of specific chromosomal aberrations. Here we present Results of CGH analysis of 56 clinically well-characterized set of head and ne...

Full description

Saved in:
Bibliographic Details
Main Authors: Mario Hermsen, Marta Alonso Guervós, Gerrit Meijer, Paul van Diest, Carlos Suárez Nieto, Cesar Alvarez Marcos, Andrés Sampedro
Format: Article
Language:English
Published: Wiley 2005-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.1155/2005/407216
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559036854173696
author Mario Hermsen
Marta Alonso Guervós
Gerrit Meijer
Paul van Diest
Carlos Suárez Nieto
Cesar Alvarez Marcos
Andrés Sampedro
author_facet Mario Hermsen
Marta Alonso Guervós
Gerrit Meijer
Paul van Diest
Carlos Suárez Nieto
Cesar Alvarez Marcos
Andrés Sampedro
author_sort Mario Hermsen
collection DOAJ
description Invasive head and neck squamous carcinomas are among the cytogenetically most complex tumors. Perhaps for this reason, there is little consensus on the prognostic value of specific chromosomal aberrations. Here we present Results of CGH analysis of 56 clinically well-characterized set of head and neck cancers, consisting of larynx and pharynx only. The aim was to find possible associations with clinical outcome. The major chromosome arms showing gains were (in decreasing order): 3q, 7q, 8q, 5p, 11q13, 17q and 18p, and losses occurred at 3p, 11qter, 4p, 18q, and 5q. The segments most frequently amplified were 3q26-qter, 11q13, 11q22, 3q12–13, 18p11.3, 18q11.2 and 8q24.3. Tumors with stages III and IV, and lymph node positive tumors had a worse clinical outcome. Surprisingly, no specific chromosomal abnormality correlated with disease-free survival. The only aberration that correlated to one of the clinico-pathological parameters was amplification 11q13, that occurred solely in lymph node positive, stage IV tumors. However 11q13 amplification did not correlate with disease-free survival. These Results seem to indicate that genetic alterations at the level of chromosomes have limited prognostic value in patients with invasive larynx and pharynx squamous cell carcinomas.
format Article
id doaj-art-dc2514a5e0f5424a8bfcf84dacabee3f
institution Kabale University
issn 1570-5870
1875-8606
language English
publishDate 2005-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-dc2514a5e0f5424a8bfcf84dacabee3f2025-02-03T01:30:59ZengWileyCellular Oncology1570-58701875-86062005-01-0127319119810.1155/2005/407216Chromosomal Changes in relation to Clinical Outcome in Larynx and Pharynx Squamous Cell CarcinomaMario Hermsen0Marta Alonso Guervós1Gerrit Meijer2Paul van Diest3Carlos Suárez Nieto4Cesar Alvarez Marcos5Andrés Sampedro6Department of Otolaryngology, IUOPA, Hospital Universitario Central de Asturias, Oviedo, SpainCytometry Service, IUOPA, University of Oviedo, Oviedo, SpainDepartment of Pathology, VUmc, Amsterdam, The NetherlandsDepartment of Pathology, VUmc, Amsterdam, The NetherlandsDepartment of Otolaryngology, IUOPA, Hospital Universitario Central de Asturias, Oviedo, SpainDepartment of Otolaringology, Valle del Nalón Hospital, Oviedo, SpainCytometry Service, IUOPA, University of Oviedo, Oviedo, SpainInvasive head and neck squamous carcinomas are among the cytogenetically most complex tumors. Perhaps for this reason, there is little consensus on the prognostic value of specific chromosomal aberrations. Here we present Results of CGH analysis of 56 clinically well-characterized set of head and neck cancers, consisting of larynx and pharynx only. The aim was to find possible associations with clinical outcome. The major chromosome arms showing gains were (in decreasing order): 3q, 7q, 8q, 5p, 11q13, 17q and 18p, and losses occurred at 3p, 11qter, 4p, 18q, and 5q. The segments most frequently amplified were 3q26-qter, 11q13, 11q22, 3q12–13, 18p11.3, 18q11.2 and 8q24.3. Tumors with stages III and IV, and lymph node positive tumors had a worse clinical outcome. Surprisingly, no specific chromosomal abnormality correlated with disease-free survival. The only aberration that correlated to one of the clinico-pathological parameters was amplification 11q13, that occurred solely in lymph node positive, stage IV tumors. However 11q13 amplification did not correlate with disease-free survival. These Results seem to indicate that genetic alterations at the level of chromosomes have limited prognostic value in patients with invasive larynx and pharynx squamous cell carcinomas.http://dx.doi.org/10.1155/2005/407216
spellingShingle Mario Hermsen
Marta Alonso Guervós
Gerrit Meijer
Paul van Diest
Carlos Suárez Nieto
Cesar Alvarez Marcos
Andrés Sampedro
Chromosomal Changes in relation to Clinical Outcome in Larynx and Pharynx Squamous Cell Carcinoma
Cellular Oncology
title Chromosomal Changes in relation to Clinical Outcome in Larynx and Pharynx Squamous Cell Carcinoma
title_full Chromosomal Changes in relation to Clinical Outcome in Larynx and Pharynx Squamous Cell Carcinoma
title_fullStr Chromosomal Changes in relation to Clinical Outcome in Larynx and Pharynx Squamous Cell Carcinoma
title_full_unstemmed Chromosomal Changes in relation to Clinical Outcome in Larynx and Pharynx Squamous Cell Carcinoma
title_short Chromosomal Changes in relation to Clinical Outcome in Larynx and Pharynx Squamous Cell Carcinoma
title_sort chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma
url http://dx.doi.org/10.1155/2005/407216
work_keys_str_mv AT mariohermsen chromosomalchangesinrelationtoclinicaloutcomeinlarynxandpharynxsquamouscellcarcinoma
AT martaalonsoguervos chromosomalchangesinrelationtoclinicaloutcomeinlarynxandpharynxsquamouscellcarcinoma
AT gerritmeijer chromosomalchangesinrelationtoclinicaloutcomeinlarynxandpharynxsquamouscellcarcinoma
AT paulvandiest chromosomalchangesinrelationtoclinicaloutcomeinlarynxandpharynxsquamouscellcarcinoma
AT carlossuareznieto chromosomalchangesinrelationtoclinicaloutcomeinlarynxandpharynxsquamouscellcarcinoma
AT cesaralvarezmarcos chromosomalchangesinrelationtoclinicaloutcomeinlarynxandpharynxsquamouscellcarcinoma
AT andressampedro chromosomalchangesinrelationtoclinicaloutcomeinlarynxandpharynxsquamouscellcarcinoma